Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks

J Dermatolog Treat. 2022 Dec;33(8):3211-3213. doi: 10.1080/09546634.2022.2125265. Epub 2022 Sep 26.

Authors

Luca Mastorino¹, C Cariti¹, S Susca¹, S Boskovic¹, C Aquino¹, M Ortoncelli¹, E Stroppiana¹, A Verrone¹, P Dapavo¹, P Quaglino¹, Simone Ribero¹

Affiliation

¹ Dermatology Clinic, Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy.

PMID: 36103200
DOI: 10.1080/09546634.2022.2125265

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / therapeutic use
Humans
Psoriasis* / drug therapy
Severity of Illness Index
Treatment Outcome

Substances

brodalumab
Antibodies, Monoclonal, Humanized